This study was designed to follow the transcriptome changes during BMP2 mediated transformation of the MCF10A human mammary stem cell model. We found that long-term BMP2/IL6 exposure of MCF10A cells,
Genome and transcriptome sequence data from a metastatic high grade sarcomatous neoplasm nos patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) studyEGA dataset EGAD0
Agilent gene expression arrays were used to compare proliferation signatures between pre-treatment and 2-4 weeks post treatment samples from Z1031B patients. 109 patients from clinical trial NCT002657